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Norfloxacin is a quinolone (pyridonecarboxylic acid derivative) effective against Pseudomonas aeruginosa
infections. We studied the effects of this drug on DNA metabolism in P. aeruginosa. Norfloxacin inhibits DNA
replication immediately on its addition to a logarithmically growing culture of P. aeruginosa. It inhibits the
ability of P. aeruginosa DNA gyrase to supercoil relaxed, closed circular DNA in vitro. At intermediate
concentrations of the drug, inhibition of DNA replication in vivo is followed by secondary (recovery) synthesis.
Both recovery synthesis and the bactericidal effects of norfloxacin are dependent on continued protein
synthesis, suggesting that these are inducible functions. Neither norfloxacin nor nalidixic acid induces
Weigle-reactivation (inducible DNA repair) or mutagenesis in P. aeruginosa.
Quinolones (pyridonecarboxylic acid derivatives) are an-
timicrobial agents that are effective against many gram-
negative bacteria. Norfloxacin has been shown to be a potent
antimicrobial agent which acts against a broad spectrum of
bacteria (10, 11). Quinolones appear to inhibit DNA synthe-
sis by inhibiting the activity of DNA gyrase (topoisomerase
II), an enzyme responsible for ATP-dependent negative
supercoiling ofDNA (8, 16). Superhelicity ofDNA has been
shown to be required for DNA replication, RNA transcrip-
tion, recombination, and DNA repair (for a review, see
reference 7). Engle et al. (6) have suggested that these drugs
inhibit DNA replication in Escherichia coli by forming a tight
complex between DNA gyrase and DNA which inhibits
replication fork migration. On treatment with the drug, there
is an immediate inhibition of DNA synthesis. Secondary
DNA synthesis following inhibition is possible in Rec+
strains of E. coli but not in Rec- strains (6). RNA and
protein synthesis are inhibited by higher concentrations of
quinolones (19). In E. coli cell death occurs at concentra-
tions of these drugs that inhibit DNA synthesis but have little
effect on RNA and protein synthesis (19).
Pseudomonas aeruginosa is not inhibited by most
quinolones (11), and DNA gyrase from P. aeruginosa is
more resistant to inhibition by nalidixic acid than is gyrase
from E. coli (16). Norfloxacin, however, has been shown to
be an effective antimicrobial agent against P. aeruginosa (10,
11). The study we report here was designed to measure the
effects of norfloxacin on in vivo DNA replication and growth
in P. aeruginosa.
(Portions of this work will be submitted by D.M.B. to the
Graduate College, Loyola University of Chicago, in partial
fulfillment of the requirements of the degree of Doctor of
Philosophy.)
MATERIALS AND METHODS
Strains and media. All strains used in this study (Table 1)
were derived from the prototrophic strain PA01 (17) and were
maintained in Luria broth (LB) (15). All experiments were
carried out in Pseudomonas minimal medium (15) containing
0.4% glucose and 0.01% arginine. Mueller-Hinton medium
was used to determine the MICs and MBCs for norfloxacin
* Corresponding author.
(gift ofMerck Sharp & Dohme, West Point, Pa.) and nalidixic
acid for the strains described above (2, 22). These drugs were
dissolved in 0.1 N NaOH.
Rate of DNA synthesis. The rate of DNA synthesis in a
logarithmically growing culture was determined by a modi-
fication of the method of Engle et al. (6). Nucleic acid was
pulse-labeled with 1 ,uCi of [2,8-3H]adenine (29 Ci/mmol). At
various times, 0.2 ml of the culture was added to 0.8 ml of
prewarmed Pseudomonas minimal medium containing glu-
cose, arginine, the appropriate drug(s), and the radioactive
label and incubated for 4 min at 37°C. The reaction was
terminated with NaOH (final concentration, 0.3 N) and
EDTA (final concentration, 0.1%), and RNA was hydro-
lyzed by incubating the samples at 37°C overnight. Forty
micrograms of bovine serum albumin was added to each
sample; and the DNA was precipitated with 5% (final con-
centration) trichloroacetic acid, collected onto cellulose ni-
trate filters, and counted in a Beckman LS 7500 scintillation
counter.
Rate of protein synthesis. A growing culture of bacteria in
the early log phase was treated with drug(s) as described
below, exposed to 1 ,uCi of L-[4,5-3H]leucine (6 Ci/mmol),
and incubated with shaking at 37°C. At various times, 0.2-ml
samples were removed, 40 ,ug of bovine serum albumin was
added, and the samples were precipitated with ice-cold
trichloroacetic acid (final concentration, 5%). The precipi-
tate was collected onto nitrocellulose filters and counted.
Effect of antibiotics on growth of P. aeruginosa. A logarith-
mically growing culture in LB was divided into several
fractions and added to flasks containing various combina-
tions of antibiotics (nalidixic acid, norfloxacin, or chloram-
phenicol). These were incubated with shaking at 37°C; and
0.1-ml samples were removed at various times, diluted, and
plated in triplicate on plates with LB containing 1.5% agar.
These were incubated overnight at 37°C and the number of
CFU/ml was determined.
Weigle-reactivation and Weigle-mutagenesis. A logarithmi-
cally growing culture of bacteria was treated with antibiotic.
At various times 0.2-ml samples were removed and infected
with phage D3 (15) which had been exposed to UV radiation
(30 J/m2). After 7 min at room temperature, 2.5 ml of lambda
top agar (15) was added, and the mixture was plated onto
plates with LB containing 1.5% agar. After incubation at
1
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TABLE 1. Strains used this study
Nalidixic acid Norfloxacin
MIC MBC ReferenceStrain Genotypea (IC MBC MIC MBC or sourec
MI) ml) (gm)(L/l
PA0303 argB21 350 >700 0.4 16 15
RM8 argB21, les-908 700 >700 1.6 16 15
RM168 argB21, nor-901 3,000 NDb 8.0 20 This study
a Abbreviations: arg, arginine; les, lysogeny establishment; nor, resistance to norfloxacin.
b ND, Not determined.
37°C overnight, the number of PFU was determined. The
plaques were scored for clear plaque morphology as a
measure of the frequency of mutagenesis.
Purification of P. aeruginosa DNA gyrase. DNA gyrase was
purified from PA0303 by a modification of the methods of
Miller and Scurlock (16) and Staudenbauer and Orr (18).
Pans (40 by 24 cm) with LB containing 1.5% agar were
inoculated and incubated overnight at 37°C. Cells were
harvested, washed in 100 ml of 0.85% NaCl, and suspended
in a 10% sucrose solution prepared in 50 mM Tris hydro-
chloride (pH 8.0) at a concentration of 0.5 g/ml. The suspen-
10A
U.
Ud
sion was frozen in dry ice-ethanol and thawed at 25°C, and
0.1 ml of a freshly prepared solution of lysozyme (2 mg/ml of
water) was added for each milliliter of cell suspension. This
mixture was incubated at 0°C for 60 min and centrifuged at
35,000 x g for 30 min. Magnesium acetate was added to the
supernatant fluid to a final concentration of 5 mM, and the
extract was centrifuged at 30,000 rpm for 4 h in a Beckman
50 Ti rotor. The supernatant fluid was loaded onto a
novobiocin-Sepharose column and washed with buffer A (0.2
M KCl, 5 mM dithiothreitol, 10% glycerol, 50 mM Tris
hydrochloride [pH 8.0]) until the optical density at 280 nm
Time (h)
FIG. 1. Logarithmically growing cultures of PA0303 (A) and RM8 (B) were divided. Portions were treated with 700 ,ug of nalidixic acid
per ml (O ), 16 ,ug of norfloxacin per ml (0), 500 ,ug of chloramphenicol per ml (E), nalidixic acid and chloramphenicol (*), norfloxacin and
chloramphenicol (0), or buffer without added drug (A), as described in the text. At various times, samples were taken and the number ofCFU
per milliliter of culture was determined.
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reached a minimum. DNA gyrase was eluted from the
column with 5 M urea in buffer A. Fractions were diazlyzed
against a solution of 1 mM EDTA-5 mM dithiothreitol-10%
glycerol-50 mM Tris hydrochloride (pH 7.5) and assayed for
supercoiling activity.
DNA gyrase supercoiling assay. One unit of P. aeruginosa
DNA gyrase (16) was incubated with 0.5 ,ug of relaxed closed
circular 4XX174 DNA at 37°C in a reaction mixture (40 ,ul)
containing 20 mM KCl, 10 mM MgCl2, 2 mM dithiothreitol,
1.5 mM ATP, 5 mM supermidine chloride, and 50 mM Tris
hydrochloride (pH 7.6). After 30 min, 7 ,ul of a mixture of
20% Ficoll and 40 ,ug of bromophenol blue per ml of water
was added. Samples were loaded onto a 0.8% agarose gel,
electrophoresed, stained, and photographed as previously
described (16).
RESULTS
Inhibitory effects of norfloxacin on P. aeruginosa. The
potency of norfloxacin and nalidixic acid as bacteriostatic
and bactericidal agents for the strains to be used in this study
was determined by measuring the MIC and MBC of both
drugs (Table 1). These MICs and MBCs were consistent with
those determined for other strains of P. aeruginosa (10, 11).
Norfloxacin was several hundred- to a thousand-fold more
potent than nalidixic acid. A spontaneous norfloxacin-
resistant mutant of PA0303 (RM168) was found to have also
acquired resistance to nalidixic acid.
Bactericidal action. When P. aeruginosa PA0303 was
exposed to nalidixic acid or norfloxacin at a concentration
equal to the MBC for these drugs, the number of CFU
recovered was drastically reduced (Fig. 1A). When chloram-
phenicol was also present in the culture medium at a
concentration which completely inhibited protein synthesis
(data not shown), it eliminated the bactericidal effects of
nalidixic acid and norfloxacin. Any reduction in the number
of CFU per milliliter could be attributed to the inhibitory
effect of chloramphenicol alone. Similar results were ob-
tained when RNA synthesis was inhibited with rifampin
(data not shown).
Periodically during this experiment, a sample was re-
moved from each of the cultures and examined under a light
microscope. Even though the viability of quinolone-treated
cultures was decreased by a factor of 104 after 8 h, both
filamentous and unit-length cells were observed. Some
septation of nonfilamented cells was observed even after 8 h
of treatment.
Effects of exposure to norfloxacin on DNA replication. The
initial inhibition ofDNA synthesis by various concentrations
of norfloxacin was measured. The amount ofDNA synthesis
taking place immediately on the addition of the drug was
measured by pulse-labeling the culture for 4 min with[3H]adenine. Label was added concurrently with the drug,
and incorporation into acid-insoluble, alkali-resistant mate-
rial was determined as described above. With increasing
concentrations of norfloxacin, there was a dramatic increase
in the inhibition of DNA synthesis up to a plateau (Fig. 2).
Similar dose-response characteristics were observed with
nalidixic acid (data not shown).
The kinetics of inihibition of DNA synthesis by norflox-
acin and nalidixic acid were determined as described above.
Intermediate concentrations of the drugs led to partial inhi-
bition ofDNA synthesis (Fig. 3A and B). This inhibition was
followed by a secondary increase in DNA synthesis (recov-
ery synthesis). Complete inhibition was observed at higher
concentrations (the MBC) of norfloxacin, and no recovery
synthesis was observed (Fig. 3B).
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FIG. 2. A logarithmically growing culture of PA0303 was di-
vided and exposed to various concentrations of norfloxacin. DNA
synthesis was measured by pulse-labeling with [3H]adenine for 4
min. The label was added to the culture medium concurrently with
the drug.
The effects on protein synthesis of nalidixic acid and
norfloxacin at four times the MIC were tested. Nalidixic acid
was found to completely (>99%) inhibit protein synthesis
after 10 min of exposure, while norfloxacin only caused a 40
to 50% inhibition (data not shown). When a combination of
chloramphenicol (500 ,ug/ml) and norfloxacin was added to a
logarithmically growing culture, protein synthesis was im-
mediately inhibited and recovery DNA synthesis was not
observed (Fig. 4A).
Induction of DNA repair and mutagenesis mechanisms.
Quinolones are known to induce the SOS response in E. coli
(21, 23). The ability of norfloxacin and nalidixic acid to
induce an error-prone DNA repair system in P. aeruginosa
was investigated. The capacity of cells exposed to these
drugs to repair UV-induced damage to bacteriophage D3 was
measured as described above. The rate of mutagenesis was
scored by the frequency of clear-plaque mutants among the
repaired phages. Neither increased capacity to repair DNA
damage nor mutagenic potential was observed on treatment
with either of the drugs (Fig. 5 and Table 2). During the
course of the experiment, the phage titer remained constant
when phage were plated on untreated cells.
In vitro effects of norfloxacin on isolated P. aeruginosa DNA
gyrase. DNA gyrase was purified from PAO303, and the
ability of norfloxacin and nalidixic acid to inhibit the
supercoiling reaction was assessed in vitro. Both drugs
inhibited this reaction significantly under the conditions
tested (Fig. 6, lanes 4 and 5, respectively).
Effects of norfloxacin in a Rec- mutant. RecA- strains of
E. coli are unable to undergo recovery synthesis after
treatment with quinolones (6). lesB mutations of P. aerugi-
nosa have many characteristics which are similar to muta-
VOL. 29, 1986
4 BENBROOK AND MILLER
S
= 50
z
20
20
0 20 40 0 20 40 0 20 40
Time (mlii)
FIG. 3. Logarithmically growing cultures of PA0303 (A and B) and RM8 (C) were divided. One portion of the culture was treated with
either four times the MIC (0) or the MBC (A) concentration of nalidixic acid (A) or norfloxacin (B and C). The remaining portion was not
treated (@). At various times after introduction of the drug, samples were taken, and the rate of DNA synthesis was measured as described
in the text.
tions in the recA gene of E. coli (15). When the experiments
to determine the bactericidal effects of norfloxacin and
nalidixic acid were repeated with the lesB908 strain RM8,
this strain was killed by the drugs. However, chloramphen-
icol did not alleviate the bactericidal effects of nalidixic acid
or norfloxacin (Fig. 1B). Microscopic examination of cells
from these treated cultures revealed that some cells had
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filamented, while others were of unit length and showed
signs of septation. Simultaneous treatment with either nor-
floxacin or nalidixic acid-chloramphenicol did not prevent
this lethal unbalanced growth.
When the effects of norfloxacin on the rate of DNA
synthesis was tested in the lesB908 strain, only partial
inhibition of DNA synthesis followed by recovery synthesis
was observed at both the low (four times the MIC) and high
(MBC) concentrations of norfloxacin (Fig. 3C). When chlor-
amphenicol was added concurrently with norfloxacin, recov-
ery synthesis was initiated but was not sustained (Fig. 4B).
DISCUSSION
Treatment with norfloxacin (at MBC concentrations)
caused dramatic reductions in viable cells (CFU per millili-
ter) when protein synthesis was allowed to continue. These
killing effects were eliminated in Les' srains when protein
synthesis was inhibited. These results are similar to the
findings of Stevens (19), who suggested that the killing of E.
coli by quinolones is caused by an increase in cell volume
without cell division. Such irreversible filamentation is
known to cause death in Ion (1, 9) and tif (3, 4, 9) mutants of
E. coli. When protein synthesis is inhibited, there is no
filamentation and, hence, no cell death. Quinolone-treated
P. aeruginosa cultures contain filamentous and unit-length
cells, even though these cells are no longer viable. This
FIG. 4. Logarithmically growing cultures of PA0303 (A) and
RM8 (B) were divided, and portions were exposed to chloramphen-
icol (U), chloramphenicol and norfloxacin (0), or buffer without
added drugs (0). At various times after introduction of the drug(s),
samples were taken, and the rate ofDNA synthesis was measured as
described in the text.
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FIG. 5. At time zero, a culture of PA0303 was treated with
either nalidixic acid (0) or norfloxacin (0) at a concentration of four
times the MIC. At various times after introduction of the drug,
samples were taken and infected with UV-irradiated (30 J/m2) phage
D3. The titer of phage (PFU per milliliter) relative to the titer at time
zero (PIPO) was determined.
lethal unbalanced growth is also observed in norfloxacin-
treated cultures of E. coli (5). As quinolones are known to
have either inhibitory or stimulatory effects on the expres-
sion of specific genes (5), the actual mechanism of drug-
induced cell death may be the deregulation of the normal
growth cycle.
Engle et al. (6) have proposed that inhibition of DNA
synthesis by quinolones is due to drug-induced covalent
attachment of DNA gyrase to DNA, forming a complex
through which DNA polymerase cannot proceed. Such
complexes have been identified in vitro (7). Recovery from
inhibition of DNA synthesis by oxolinic acid at a low
concentration (four times the MIC) is hypothesized to be due
to removal of these complexes by a DNA damage-inducible
repair pathway (6). Results of the in vitro studies reported
here suggest that the site of action of notfloxacin in P.
aeruginosa is DNA gyrase. Initial inhibition ofDNA synthe-
sis followed by recovery synthesis is observed in Les'
strains of P. aeruginosa treated with norfloxacin. Recovery
synthesis in these strains is inhibited by chloramphenicol,
indicating that the induction of recovery synthesis requires
TABLE 2. Frequency of mnutagenesis in the presence of
norfloxacin or nalidixic acid'
Mutation
Time of frequency
Drug exposure (mutants
(min) per 105
PFU)
Norfloxacin 0 10
5 11
30 11
50 8
Nalidixic 0 17
5 9
30 11
50 6
a Drugs were used at concentrations of four times the MIC for each strain.
FIG. 6. The effect of norfloxacin on P. aerugihosa DNA gyrase
supercoiling activity was measured. (Lane 2) Supercoiled 4X174
(RF1) DNA (lower band) containing some open circular DNA
(upper band). (Lanes 1 and 3 through 5) Relaxed, closed circular
4174 DNA incubated under the following conditions: lane 1, no
added enzyme; lane 3, in the presence of purified P. aeruginosa
DNA gyrase under standard conditions; lanes 4 and 5, in the
presence of enzyme with norfloxacin (16 p.g/ml; lane 4) or nalidixic
acid (700 jig/ml; lane 5) added. All reactions (lanes 3 through 5)
contained one unit of P. aeruginosa DNA gyrase (16) and 0.5 jig of
DNA. They were incubated at 37°C for 30 min as described in the
text. The intermediate bands in lanes 4 and 5 have been shown to be
partially supercoiled topoisomers (7).
continued protein synthesis. Les- strains of P. aeruginosa
could not sustain recovery synthesis after treatment with
nalidixic acid, which led to a complete but delayed inhibition
of protein synthesis. These strains were able to recover and
sustain their ability to synthesize DNA after exposure to
norfloxacin, which only partially inhibited protein synthesis.
The immediate and complete inhibiton of protein synthesis
by chloramphenicol led to a recovery synthesis that could
not be sustained in these strains. The characteristics of the
Les- strain RM8 reported here suggest that this mutation
may be constitutive for both recovery synthesis and some
unmodulated lethal function. This is reminiscent of several
E. coli recA alleles recently isolated by Tessman and
Peterson (20) which are recombinationally deficient (Rec-)
but constitutive for inductive (protease) functions (Prtc).
The recA and lexA genes of E. coli control the induction of
several functions collectively called SOS functions (12, 21,
23). These functions are inducible by nalidixic acid in E. coli
(21) and include damage-inducible DNA repair and mutagen-
esis functions. Engle et al. (6) have suggested that SOS-
associated repair mechanisms may be responsible for the
recovery synthesis observed after treatment with quin-
olones. Some of these functions, if not modulated, can be
lethal to the cell (1, 3, 4, 9). Even though we have shown that
P. aeruginosa contains a genetic analog to the E. coli recA
gene (12), neither nalidixic acid nor norfloxacin induces
SOS-associated DNA repair or mutagenesis in P. aerugi-
nosa. These processes also are not induced by UV irradia-
tion (C. S. Simonson and R. V. Miller, manuscript in
preparation). This suggests that recovery synthesis in P.
aeruginosa is not dependent on a UV-inducible DNA repair
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system. The dependence of recovery synthesis on continued
RNA and protein synthesis in Rec+ strains indicates the
requirement for some inducible phenomenon. This phenom-
enon may be the induction ofDNA gyrase itself. Menzel and
Gellert (14) have shown that transcription of the structural
genes for DNA gyrase are induced by relaxed DNA in E.
coli.
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